Simplify Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Simplify Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$961K	–	137
2023 Q2	$961K	Hold	25,000	–	–	0.13%	77
2023 Q1	$579K	Buy	+25,000	New	+$596K	0.08%	80

Simplify Asset Management's KDNY Position: Q3 2023 in Review

Simplify Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 25,000 shares — an estimated $961K sold.

Simplify Asset Management first reported a position in KDNY in Q1 2023 and held it in 2 quarters. The position peaked at $961K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Simplify Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Simplify Asset Management sold 25,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $961K.
Simplify Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Simplify Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $961K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplify Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.